Please participate in our anonymous survey to help us improve our website. We are working to ensure we understand all our users needs, ahead of an exciting new redesign.
Take survey
menu

Volanesorsen and Triglyceride Levels in Familial Chylomicronaemia Syndrome

Published results from the Phase 3 APPROACH study evaluating WAYLIVRA® (Volanesorsen) in patients with familial chylomicronaemia syndrome (FCS) from the August 9th 2019 issue of The New England Journal of Medicine (NEJM) are available here.    

Published results from the Phase 3 APPROACH study evaluating WAYLIVRA® (Volanesorsen) in patients with familial chylomicronaemia syndrome (FCS) from the August 9th 2019 issue of The New England Journal of Medicine (NEJM) are available here.